Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Curran Terrie sold 38,200 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Aug 27, 2026 · Filed Aug 28, 2026
On Aug 27, 2026, Curran Terrie (Director) sold 38,200 Arcutis Biotherapeutics, Inc. shares at US$25.03 for US$956K, leaving 23,526 shares. Filed Aug 28, 2026 (Form 4).
- Sold
- 38,200 shares
- Price
- US$25.03
- Value
- US$956K
- Holding after
- 23,526 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | Option exercise | 11,148 | US$7.51 | 34,674 | Direct |
| Aug 27, 2026 | Common Stock | Sale | 11,148 | US$25.03 | 23,526 | Direct |
| Aug 27, 2026 | Common Stock | Option exercise | 27,052 | US$8.63 | 50,578 | Direct |
| Aug 27, 2026 | Common Stock | Sale | 27,052 | US$25.03 | 23,526 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Curran Terrie
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Curran Terrie · Aug 24, 2026
- Form 4 · Curran Terrie · Jun 9, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026